Product

Company

Clareo Health | MR Guidance for Liver and Pancreas

NCT03582189·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Health Network, Toronto

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Patients 18 years or older
Diagnosed with locally advanced pancreatic cancer or hepatocellular carcinoma being considered for treatment with chemoradiation, long course RT, or SBRT with curative intent or palliative intent, planned for 5 or more RT fractions

\- Contraindications for MRI: ferromagnetic prosthesis, pacemaker / implanted defibrillator, claustrophobia

The record

StatusRecruiting

PhaseNo phase

Taking part30

StartedJul 2018

UpdatedMar 5, 2026

Conditions

Where1

University Health Network - Princess Margaret Cancer Centre
Toronto, Ontario, Canada